Evidence map›Paper›PMID 24701189›Full record

ArticleTheScientificWorldJournal2014

Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal.

Rúben Fernandes, Paula Amador, Carla Oliveira, Cristina Prudêncio

Open access · goldAbstract read
In one paragraph

Article in TheScientificWorldJournal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Antimicrobial Resistance Pattern ofPathogens (Basel, Switzerland) · 2020
    Article
  7. Intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae at admission in a Portuguese hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  8. Shigella flexneri: an emerging pathogen.Folia microbiologica · 2020
    Review
  9. Review
  10. Article
  11. ESBL and AmpC β-Lactamases in Clinical Strains ofMedicina (Kaunas, Lithuania) · 2019
    Article
  12. Distribution of ExPEC Virulence Factors,Frontiers in microbiology · 2018
    Article
  13. Genetic Diversity, Multidrug Resistance, and Virulence ofFrontiers in cellular and infection microbiology · 2018
    Article
  14. Article
  15. Antimicrobial Resistance and Cytotoxicity ofFrontiers in microbiology · 2017
    Article
  16. Isolation, Antimicrobial Susceptibility Profile and Detection ofJundishapur journal of microbiology · 2016
    Article
  17. Article
  18. Occurrence and characteristics of extended spectrum beta-lactamases-producing Enterobacteriaceae from foods of animal origin.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Rúben FernandesCiências Químicas e das Biomoléculas (CQB) e Centro de Investigação em Saúde e Ambiente (CISA), Escola Superior de Tecnologia da Saúde do Porto (ESTSP), Instituto Politécnico do Porto (IPP), 4400-330 Porto, Portugal ; CFBQ-Centro de Farmacologia e Biopatologia Química (U38-FCT), Faculdade de Medicina do Porto, Porto, Portugal.ORCID 0000-0001-8933-3984
Paula AmadorDepartamento de Ciências do Ambiente, Escola Superior Agrária de Coimbra, Instituto Politécnico de Coimbra, Coimbra, Portugal.
Carla OliveiraDepartamento de Biologia Molecular, Instituto de Ciência Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal.
Cristina PrudêncioCiências Químicas e das Biomoléculas (CQB) e Centro de Investigação em Saúde e Ambiente (CISA), Escola Superior de Tecnologia da Saúde do Porto (ESTSP), Instituto Politécnico do Porto (IPP), 4400-330 Porto, Portugal ; CFBQ-Centro de Farmacologia e Biopatologia Química (U38-FCT), Faculdade de Medicina do Porto, Porto, Portugal ; Centro Hospitalar da Universidade de Coimbra (CHUC), Coimbra, Portugal.
Hospitais da Universidade de Coimbra · PTPolytechnic Institute of Coimbra · PTRede de Química e Tecnologia · PTUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended-spectrum β-lactamases (ESBLs) prevalence was studied in the north of Portugal, among 193 clinical isolates belonging to citizens in a district in the boundaries between this country and Spain from a total of 7529 clinical strains. In the present study we recovered some members of Enterobacteriaceae family, producing ESBL enzymes, including Escherichia coli (67.9%), Klebsiella pneumoniae (30.6%), Klebsiella oxytoca (0.5%), Enterobacter aerogenes (0.5%), and Citrobacter freundii (0.5%). β -lactamases genes blaTEM, blaSHV, and blaCTX-M were screened by polymerase chain reaction (PCR) and sequencing approaches. TEM enzymes were among the most prevalent types (40.9%) followed by CTX-M (37.3%) and SHV (23.3%). Among our sample of 193 ESBL-producing strains 99.0% were resistant to the fourth-generation cephalosporin cefepime. Of the 193 isolates 81.3% presented transferable plasmids harboring bla ESBL genes. Clonal studies were performed by PCR for the enterobacterial repetitive intragenic consensus (ERIC) sequences. This study reports a high diversity of genetic patterns. Ten clusters were found for E. coli isolates and five clusters for K. pneumoniae strains by means of ERIC analysis. In conclusion, in this country, the most prevalent type is still the TEM-type, but CTX-M is growing rapidly.

Indexed as

beta-LactamasesEnterobacteriaceaeIsoelectric FocusingPolymerase Chain ReactionPortugalbeta-Lactamases

Identifiers

PMID24701189
PMCPMC3950362
OpenAlexW2009703959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.